FDA approves cariprazine for treatment of depressive episodes in bipolar I disorder FDA, 제1형 양극성 장애의 우울증 치료에 카리프라진 승인
FDA approves cariprazine for treatment of depressive episodes in bipolar I disorder Reuters (5/28, Maddipatla, Joseph) reports the Food and Drug Administration approved Allergan Plc’s Vraylar (cariprazine) “to treat depressive episodes of bipolar I disorder, expanding its scope of treatment … Continued